scholarly journals P24 Audit reviewing viability of removing pre-operative Group and Save Tests prior to Transurethral Prostate Surgery during the COVID19 pandemic

BJS Open ◽  
2021 ◽  
Vol 5 (Supplement_1) ◽  
Author(s):  
Nicholas Wong
Keyword(s):  
Blood Transfusion ◽  
Retrospective Review ◽  
Patient Records ◽  
Electronic Patient Records ◽  
Patient Benefit ◽  
Single Centre ◽  
Healthcare Resources ◽  
Retrospective Audit ◽  
Single Centre Study ◽  
Transurethral Prostate Surgery

Abstract Introduction COVID19 has stressed and stretched healthcare resources to the limit, thus the rational deployment of any resource should be necessary and of patient benefit. This retrospective audit aims to ascertain if a policy of two valid group and save tests prior to transurethral prostate surgery is necessary and if this resource can be redistributed safely during the ongoing pandemic. Methods A retrospective review of electronic patient records for patients that underwent transurethral prostate surgery from June 2017 to June 2018. During a single admission for surgery it was identified how many pre-operative group and save tests, and if a post-operative blood transfusion patients underwent. Results 146 patients underwent transurethral prostate surgery between June 2017 to June 2018. 97 patients had two valid group and save tests prior to surgery. 49 patients did not have 2 valid group and save tests. 21 patients had expired tests, 20 had only one valid sample, and 8 had no group and save test at all. No patient underwent a blood transfusion during their admission for transurethral prostate surgery. Conclusion This single centre study illustrates pre-operative group and save tests before transurethral prostate surgery are unnecessary as no patient required an associated blood transfusion during admission; and can safely be omitted. The clinical time and resource could be redirected elsewhere for greater patient benefit. £2855.00 of efficiency savings could be made foregoing unneeded group and save tests. A policy omitting pre-operative group and save before transurethral prostate surgery will be implemented under COVID19 pandemic conditions and re-audited in 6 months.

Retrospective review of 200 children hospitalised with acute asthma. Identification of intervention points: A single centre study

2013 ◽  
Vol 50 (4) ◽  
pp. 286-290 ◽  
Author(s):  
Blake F Giarola ◽  
Gabrielle B McCallum ◽  
Emily J Bailey ◽  
Peter S Morris ◽  
Carolyn Maclennan ◽  
...  
Keyword(s):  
Retrospective Review ◽  
Acute Asthma ◽  
Single Centre ◽  
Centre Study ◽  
Single Centre Study

scholarly journals TP6.2.23 Does using intraoperative Tisseel reduce the leak rate in Cardio-Oesophagectomy: A single centre retrospective audit of anastomotic and chyle leaks

2021 ◽  
Vol 108 (Supplement_7) ◽  
Author(s):  
Iain Blake ◽  
Stuart Chapman ◽  
Paul Turner
Keyword(s):  
Anastomotic Leak ◽  
Thoracic Duct ◽  
Patient Records ◽  
Single Centre ◽  
Chyle Leak ◽  
Patient Demographics ◽  
Upper Gi ◽  
Retrospective Audit ◽  
Significant Difference ◽  
Tissue Sealant

Abstract Aims Anastomotic leak and chylothorax are serious complications of cardio-oesophagectomy. The application of a tissue sealant to the anastomosis and ligated thoracic duct could be beneficial in protecting against leaks. We aimed to determine if using Tisseel, a fibrin-based tissue sealant, had any impact on anastomotic or chyle leak rates following cardio-oesophagectomy. Methods All elective cardio-oesophagectomys performed in a tertiary upper GI centre between 01/01/2013 and 01/01/2018 were identified. Patient records were retrospectively analysed to assess basic demographics; whether Tisseel was used; whether anastomotic or chyle leak occurred and if so whether this was managed conservatively or surgically. Results 245 records were available, Tisseel was used in 151 cases (61.6%). Patient demographics were similar between the Tisseel and no Tisseel groups (82.7% vs 77.7% male, mean age 66 vs 65 years). There was no significant difference in anastomotic leak (4.0% vs 7.4%, p = 0.24) or chyle leak (6.6% vs 4.3%, p = 0.44) rates. For patients who had an anastomotic leak there was a significantly lower rate of re-thoracotomy when Tisseel was used (16.7% vs 85.7%, p = 0.021). There was no significant difference in re-thoracotomy rates for chyle leak (40% vs 100%, p = 0.085). Conclusion Our data does not show any significant difference in leak rates when Tisseel is used. However, it does show that Tisseel use is associated with lower rate of re-thoracotomy in patients with anastomotic leak. This could possibly be due to smaller contained leaks. Further work is needed to determine the true benefit of Tisseel use in cardio-oesophagectomy.

scholarly journals Retrospective review of retained double J stents: A single centre study

2020 ◽  
Vol 4 (4) ◽  
pp. 299-303
Author(s):  
Dr. GV Charan Kumar ◽  
Dr. Rahul Devaraj ◽  
Dr. Dheeraj ◽  
Dr. Vidya Sagar ◽  
Dr. Ramachandraiah ◽  
...  
Keyword(s):  
Retrospective Review ◽  
Single Centre ◽  
Centre Study ◽  
Single Centre Study

Electronic Patient Records in Medical Practice: A Multidisciplinary Endeavor

1999 ◽  
Vol 38 (04/05) ◽  
pp. 287-288 ◽  
Author(s):  
J. van der Lei ◽  
P. W. Moorman ◽  
M. A. Musen
Keyword(s):  
Medical Practice ◽  
Patient Records ◽  
Electronic Patient Records

Postmarketing Surveillance Based on Electronic Patient Records: The IPCI Project

1999 ◽  
Vol 38 (04/05) ◽  
pp. 339-344 ◽  
Author(s):  
J. van der Lei ◽  
B. M. Th. Mosseveld ◽  
M. A. M. van Wijk ◽  
P. D. van der Linden ◽  
M. C. J. M. Sturkenboom ◽  
...  
Keyword(s):  
General Practitioner ◽  
General Practitioners ◽  
Validation Studies ◽  
Resource Planning ◽  
Routine Practice ◽  
Patient Records ◽  
Postmarketing Surveillance ◽  
Electronic Patient Records ◽  
Use Of Data ◽  
Data Requirements

AbstractResearchers claim that data in electronic patient records can be used for a variety of purposes including individual patient care, management, and resource planning for scientific research. Our objective in the project Integrated Primary Care Information (IPCI) was to assess whether the electronic patient records of Dutch general practitioners contain sufficient data to perform studies in the area of postmarketing surveillance studies. We determined the data requirements for postmarketing surveil-lance studies, implemented additional software in the electronic patient records of the general practitioner, developed an organization to monitor the use of data, and performed validation studies to test the quality of the data. Analysis of the data requirements showed that additional software had to be installed to collect data that is not recorded in routine practice. To avoid having to obtain informed consent from each enrolled patient, we developed IPCI as a semianonymous system: both patients and participating general practitioners are anonymous for the researchers. Under specific circumstances, the researcher can contact indirectly (through a trusted third party) the physician that made the data available. Only the treating general practitioner is able to decode the identity of his patients. A Board of Supervisors predominantly consisting of participating general practitioners monitors the use of data. Validation studies show the data can be used for postmarketing surveillance. With additional software to collect data not normally recorded in routine practice, data from electronic patient record of general practitioners can be used for postmarketing surveillance.

Sign in / Sign up

Export Citation Format

Share Document